Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M475Revenue (TTM) $M427Net Margin (%)53.9Altman Z-Score4.0
Enterprise Value $M592EPS (TTM) $1.4Operating Margin %89.5Piotroski F-Score6
P/E(ttm)2.1Beneish M-Score-3.4Pre-tax Margin (%)86.4Higher ROA y-yN
Price/Book0.710-y EBITDA Growth Rate %19.7Quick Ratio14.2Cash flow > EarningsY
Price/Sales1.15-y EBITDA Growth Rate %23.0Current Ratio14.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-24.6ROA % (ttm)22.4Higher Current Ratio y-yY
Dividend Yield %13.9PEG0.1ROE % (ttm)34.9Less Shares Outstanding y-yY
Payout Ratio %28.0Shares Outstanding M166ROIC % (ttm)33.5Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PDLIJoel Greenblatt 2016-06-30 Reduce-0.05%$2.95 - $3.82
($3.33)
$ 2.74-18%Reduce -38.56%2,293,523
PDLIBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Reduce$2.95 - $3.82
($3.33)
$ 2.74-18%Reduce -0.36%297,175
PDLIJoel Greenblatt 2016-03-31 Reduce-0.04%$2.75 - $3.54
($3.12)
$ 2.74-12%Reduce -21.40%3,732,679
PDLIBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Add$2.75 - $3.54
($3.12)
$ 2.74-12%Add 5.86%298,243
PDLIJoel Greenblatt 2015-12-31 Reduce-0.01%$3.5 - $5.26
($4.16)
$ 2.74-34%Reduce -5.90%4,748,690
PDLIBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Add$3.5 - $5.26
($4.16)
$ 2.74-34%Add 1.90%281,746
PDLIJoel Greenblatt 2015-09-30 Reduce-0.12%$4.95 - $6.56
($5.73)
$ 2.74-52%Reduce -30.24%5,046,353
PDLIJoel Greenblatt 2015-06-30 Add0.21%$6.23 - $7.3
($6.7)
$ 2.74-59%Add 114.94%7,233,838
PDLIBarrow, Hanley, Mewhinney & Strauss 2015-06-30 Add$6.23 - $7.3
($6.7)
$ 2.74-59%Add 5.41%276,491
PDLIJoel Greenblatt 2015-03-31 Add0.17%$6.7 - $7.72
($7.24)
$ 2.74-62%Add 1739.03%3,365,474
PDLIBarrow, Hanley, Mewhinney & Strauss 2015-03-31 Buy $6.7 - $7.72
($7.24)
$ 2.74-62%New holding262,299
PDLIJoel Greenblatt 2014-12-31 Add0.01%$7.325 - $8.53
($7.92)
$ 2.74-65%Add 603.94%183,003
PDLIJoel Greenblatt 2014-09-30 Reduce-0.09%$7.51 - $10.26
($9.3)
$ 2.74-71%Reduce -96.71%25,997
PDLIJoel Greenblatt 2014-06-30 Reduce-0.11%$8 - $9.85
($8.9)
$ 2.74-69%Reduce -52.58%789,804
PDLIJoel Greenblatt 2014-03-31 Reduce-0.34%$7.46 - $9.14
($8.57)
$ 2.74-68%Reduce -50.19%1,665,543
PDLIJoel Greenblatt 2013-09-30 Add0.15%$7.72 - $8.44
($8.04)
$ 2.74-66%Add 24.84%2,890,564
PDLIJoel Greenblatt 2013-03-31 Add0.15%$6.65 - $7.53
($7.08)
$ 2.74-61%Add 23.50%2,135,460
PDLIJoel Greenblatt 2012-12-31 Add0.59%$7.09 - $8.37
($7.75)
$ 2.74-65%Add 561.89%1,729,133
PDLISeth Klarman 2012-03-31 Sold Out -1.5%$6.02 - $6.58
($5.93)
$ 2.74-54%Sold Out0
PDLIJoel Greenblatt 2012-03-31 Add0.04%$6.02 - $6.58
($5.93)
$ 2.74-54%Add 33.54%270,346
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PDLI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GARCIA PETER SVice President, CFO 2016-08-09Buy10,000$3-8.67view
GARCIA PETER SVice President, CFO 2015-12-15Buy15,000$3.5-21.71view
Pietzke SteffenController and CAO 2015-12-07Buy20,590$3.64-24.73view
GARCIA PETER SVice President, CFO 2015-08-14Buy20,000$5.83-53view
SELICK HAROLD EDirector 2014-11-26Buy6,000$8.08-66.09view
Lindell Jody SDirector 2011-03-15Buy374$5.33-48.59view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.71-52.01view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.18-55.66view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.33-67.11view
Lindell Jody SDirector 2009-06-15Buy3,000$7.76-64.69view

Press Releases about PDLI :

Quarterly/Annual Reports about PDLI:

News about PDLI:

Articles On GuruFocus.com
Undervalued Companies With Growing EPS Apr 04 2016 
Cash is Flowing Nicely for These Five Stocks Aug 19 2015 
Context Capital Management's Top Buys in Q2 2015 Jul 15 2015 
Weekly 3-Year Low Highlights: APOL, PDLI, TC, ALLT, ELRC May 17 2015 
Hot Picks with High Yields Jul 23 2013 
My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 Feb 27 2013 
20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013 
Seth Klarman’s Investment Framework Sep 15 2012 

More From Other Websites
ETF’s with exposure to PDL BioPharma, Inc. : August 22, 2016 Aug 22 2016
PDL BIOPHARMA, INC. Financials Aug 12 2016
PDL BioPharma, Inc. :PDLI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 Aug 10 2016
ETF’s with exposure to PDL BioPharma, Inc. : August 9, 2016 Aug 09 2016
PDL BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : PDLI-US : August 8,... Aug 08 2016
PDL BioPharma (PDLI) Stock Plummets on Q2 Revenue Miss Aug 05 2016
Edited Transcript of PDLI earnings conference call or presentation 4-Aug-16 8:30pm GMT Aug 04 2016
PDL BioPharma posts 2Q profit Aug 04 2016
PDL BioPharma posts 2Q profit Aug 04 2016
PDL BioPharma Announces Second Quarter 2016 Financial Results Aug 04 2016
PDL BioPharma Announces Elimination of Quarterly Cash Dividend Aug 04 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Aug 04 2016
PDL BioPharma Announces Second Quarter 2016 Financial Results Aug 04 2016
PDL BioPharma Announces Elimination of Quarterly Cash Dividend Aug 04 2016
Q2 2016 PDL BioPharma Inc Earnings Release - After Market Close Aug 04 2016
PDL BIOPHARMA, INC. Files SEC form 8-K/A, Financial Statements and Exhibits Aug 03 2016
PDL BioPharma Completes Second Tranche Payment Under Royalty Transaction with ARIAD Pharmaceuticals Aug 01 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 01 2016
PDL BioPharma Completes Second Tranche Payment Under Royalty Transaction with ARIAD Pharmaceuticals Aug 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)